{
    "nctId": "NCT05739591",
    "briefTitle": "Long-term Safety and Efficacy of GBG Study Participants",
    "officialTitle": "Registry for Long-term Follow-up of Safety and Efficacy Parameters of GBG Study Participants",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Disease-free survival (DFS)",
    "eligibilityCriteria": "Inclusion criteria:\n\n* Participation and treatment in a GBG clinical trial for early breast cancer.\n* Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.\n\nExclusion criteria:\n\n* Participation and treatment in a non-GBG clinical trial for early breast cancer.\n* Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}